- $50.27m
- $67.37m
- $22.36m
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:57 AM
DarioHealth Corp reports results for the quarter ended June 30 - Earnings Summary
DarioHealth Q2 revenue falls on pharma exit; gross margin improves
DarioHealth Corp expected to post a loss of $1.21 a share - Earnings Preview
Brief: Dario Launches Integrated Glp-1 Program, Combining Its Digital Chronic Care Platform With Provider-Backed Clinical Care In A Single End-To-End Experience
Brief: Dariohealth Corp Files For Offering Of Up To 2.5 Million Shares Of Common Stock - SEC Filing
NASDAQ RESUMED AT 09:51 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:41 AM
DarioHealth Q1 revenue rises sequentially, operating loss narrows on cost reductions
NASDAQ RESUMED AT 12:55 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:50 PM
DarioHealth Q4 revenue beats estimates, net loss narrows on lower expenses
Brief: Dariohealth Corp - Sees Increased Demand For Oral Glp-1 Solution
U.S. RESEARCH ROUNDUP-Disney, Enanta Pharmaceuticals, Phillips 66
DarioHealth misses Q3 revenue estimates
Brief: DarioHealth And OneStep Announce Collaboration To Integrate Smartphone-Only
US. STOCKS ON THE MOVE-Vertex, IBM, Silver Miners
US. STOCKS ON THE MOVE-Vertex, IBM, silver miners
U.S. STOCKS ON THE MOVE- Birkenstock, CME Group, Citigroup